Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$205.6K
40K shares
What this filing means
HECHT BETH plans to sell 40K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $205.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/20/2025ACC: 0001972362-25-000326
Officer· See Remarks
Since Oct 2021
40K
Shares to sell
$205.6K
Approx. market value
40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
RESTRICTED STOCK
COMPENSATION
1/29/2024
24.86KESPP
COMPENSATION
6/30/2021
3KRESTRICTED STOCK
COMPENSATION
1/31/2021
10.55KESPP
COMPENSATION
12/31/2019
459.00ESPP
COMPENSATION
6/30/2019
1.12KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/29/2024 | RESTRICTED STOCK COMPENSATION | 24.86K | — |
6/30/2021 | ESPP COMPENSATION | 3K | — |
1/31/2021 | RESTRICTED STOCK COMPENSATION | 10.55K | — |
12/31/2019 | ESPP COMPENSATION | 459.00 | — |
6/30/2019 | ESPP COMPENSATION | 1.12K | — |
| Total | 40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
40K
Market value
$205.6K
3/20/2025
Total
Units
40K
Value
$205.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/20/2025 | 40K | $205.6K | NASDAQ | Planned |
| Total | 40K | $205.6K | ||